Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:48 PM
Ignite Modification Date:
2025-12-24 @ 5:48 PM
NCT ID:
NCT02986568
Eligibility Criteria:
Inclusion Criteria:
* Female, Age ≥ 20 years
* Patients with primary, recurrent, or refractory cervical cancer (FIGO stage IB1-IVA), primary, recurrent, or refractory uterine cancer (FIGO stage IA, grade 3, IB-IVA), or gynecologic cancer patients showing pelvic sidewall recurrence.
* ECOG performance status 0 or 1
* Extensive surgery might be expected to cure the disease, or expected to relieve severe pelvic pain.
* Patients who signed an approved informed consent
* Patients who do not have a treatment option other than surgery.
Exclusion Criteria:
* Female, Age \< 20 years
* ECOG performance status ≥2
* Bilateral pelvic sidewall invasion
* Patients who had undergone radical hysterectomy, trachelectomy, or hysterectomy in case of the primary disease.
* Patients who refused to sign an informed consent
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
20 Years
Study:
NCT02986568
Study Brief:
Protocol Section:
NCT02986568